circRNA basic information
circBase ID: hsa_circ_0017264
Name: hsa_circ_ADSS
Synonym: -
Host Gene: ADSS
Genomic location(hg19): chr1:244579282-244587689:-
Genomic location(hg38): chr1:244415980-244424387:-
Subcellular localization: not tested
 
 
 
 
 
 
 
Disease basic information
MONDO ID:
0007256
MONDO name: hepatocellular carcinoma
Disease details: hepatocellular carcinoma / HCC
Disease DO ID:
684, 686
Disease MeSH ID:
D006528
Disease NCIt ID:
C3099
Disease ICD11 ID:
1294035808
Disease OMIM ID:
114550
Species: Human
Species details: Homo sapiens
Tissue specimen:

tumor tissue; adjacent normal tissue

Cell lines:

-

In vivo animal model:

-

circRNA-disease information
Expression pattern:
UP
Associated gene: CHEK1, CDC25A, FOXK1
Associated microRNA: hsa-miR-195-5p
Biological function: May contribute to LIHC onset and progression; the axis may be involved in facilitating immune escape in the LIHC microenvironment.
Molecular mechanism: ceRNA network: hsa_circ_0017264 sponges hsa-miR-195-5p to regulate CHEK1/CDC25A/FOXK1.
Biological pathway or process:

ceRNA regulation (other); cell cycle (promotes); p53 signaling (promotes); Wnt/beta-catenin (promotes); immune regulation (other)

Detected method:
Q
M
Validation methods:

Microarray; Bioinformatics Analysis; RT-qPCR; Clinical Sample Validation; divergent primers PCR; Sanger Sequencing; Survival Analysis

Clinical significance:

Survival-related ceRNA network; may provide potential prognostic biomarkers and therapeutic targets for LIHC.

Description:

hsa_circ_0017264 is up-regulated in LIHC tissues and is proposed to act in a ceRNA network by sequestering hsa-miR-195-5p, thereby affecting CHEK1/CDC25A/FOXK1. This axis is linked to cell-cycle and cancer-related pathways and is associated with immune infiltration/immune checkpoint correlations, suggesting a role in LIHC progression and immune escape.

Confidence score:

0.6556

Other information
Title:

Identification of a Novel Survival-Related circRNA-miRNA-mRNA Regulatory Network Related to Immune Infiltration in Liver Hepatocellular Carcinoma.

Journal: Frontiers in genetics
Published: 2022
PubMed ID: 35309118
Study type:

combined biological and clinical study

Data availability: GSE164803; https://www.frontiersin.org/articles/10.3389/fgene.2022.800537/full#supplementary-material
Code availability: -